Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Sacubitril | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Sacubitril | hsa00040 | Pentose and glucuronate interconversions | 9.59E-03 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Sacubitril | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Sacubitril | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Sacubitril | hsa00100 | Steroid biosynthesis | 4.70E-02 | 1 | P35610 | SOAT1 | More | | Sacubitril | hsa00190 | Oxidative phosphorylation | 3.97E-04 | 4 | Q16718, Q13488, P36542, O14521 | NDUFA5, TCIRG1, ATP5C1, SDHD | More | | Sacubitril | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Sacubitril | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Sacubitril | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Sacubitril | hsa00500 | Starch and sucrose metabolism | 2.74E-03 | 4 | O43451, P46976, P35557, P06737 | MGAM, GYG1, GCK, PYGL | More | | Sacubitril | hsa00512 | Mucin type O-glycan biosynthesis | 1.22E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Sacubitril | hsa00513 | Various types of N-glycan biosynthesis | 4.83E-02 | 1 | Q9NR34 | MAN1C1 | More | | Sacubitril | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Sacubitril | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 4.70E-02 | 1 | P35557 | GCK | More | | Sacubitril | hsa00561 | Glycerolipid metabolism | 7.94E-03 | 3 | P15121, P14550, Q86XP1 | AKR1B1, AKR1A1, DGKH | More | | Sacubitril | hsa00564 | Glycerophospholipid metabolism | 1.97E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Sacubitril | hsa00565 | Ether lipid metabolism | 3.00E-03 | 1 | Q8N661 | TMEM86B | More | | Sacubitril | hsa00591 | Linoleic acid metabolism | 4.83E-02 | 1 | P11712 | CYP2C9 | More | | Sacubitril | hsa00600 | Sphingolipid metabolism | 2.68E-02 | 2 | P07602, Q13510 | PSAP, ASAH1 | More | | Sacubitril | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.32E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Sacubitril | hsa00730 | Thiamine metabolism | 3.79E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Sacubitril | hsa00750 | Vitamin B6 metabolism | 3.56E-02 | 1 | O00764 | PDXK | More | | Sacubitril | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Sacubitril | hsa00830 | Retinol metabolism | 4.70E-03 | 3 | P00325, O75911, P11712 | ADH1B, DHRS3, CYP2C9 | More | | Sacubitril | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Sacubitril | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Sacubitril | hsa00983 | Drug metabolism - other enzymes | 1.91E-04 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Sacubitril | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.56E-02 | 1 | P50213 | IDH3A | More | | Sacubitril | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Sacubitril | hsa01522 | Endocrine resistance | 4.55E-02 | 5 | P14780, P22694, Q9UM47, P10415, Q13323 | MMP9, PRKACB, NOTCH3, BCL2, BIK | More | | Sacubitril | hsa01524 | Platinum drug resistance | 4.42E-02 | 3 | P10415, Q13489, P23025 | BCL2, BIRC3, XPA | More | | Sacubitril | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Sacubitril | hsa03008 | Ribosome biogenesis in eukaryotes | 6.80E-05 | 6 | Q9NYH9, O14980, O60832, P78345, Q9BVP2, Q9GZY0 | UTP6, XPO1, DKC1, RPP38, GNL3, NXF2; NXF2B | More | | Sacubitril | hsa03010 | Ribosome | 2.08E-04 | 11 | P30050, P40429, P62906, P62917, P46777, Q9H0U6, P36578, P50914, P05386, P62249, P23396 | RPL12, RPL13A, RPL10A, RPL8, RPL5, MRPL18, RPL4, RPL14, RPLP1, RPS16, RPS3 | More | | Sacubitril | hsa03013 | RNA transport | 5.12E-10 | 22 | O14980, P52298, Q09161, O14893, P61326, P38919, Q9GZY0, P37198, Q7Z3B4, P35658, P47813, Q14152, P55884, O75822, P78345, Q14240, Q9BZI7, P23588, Q9Y6A5, Q06787, P51114, Q53GS7 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, EIF4A3, NXF2; NXF2B, NUP62, NUP54, NUP214, EIF1AX, EIF3A, EIF3B, EIF3J, RPP38, EIF4A2, UPF3B, EIF4B, TACC3, FMR1, FXR1, GLE1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14980 | XPO1 | Exportin-1 | 0.799 | Q92769 | HDAC2 | Histone deacetylase 2 | O14980 | XPO1 | Exportin-1 | 0.75 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.915 | Q92769 | HDAC2 | Histone deacetylase 2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.766 | P08246 | ELA2 | Neutrophil elastase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | -0.852 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.771 | P08246 | ELA2 | Neutrophil elastase | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | -0.732 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.72 | Q92769 | HDAC2 | Histone deacetylase 2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.734 | P08246 | ELA2 | Neutrophil elastase | O14893 | GEMIN2 | Gem-associated protein 2 | -0.785 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P61326 | MAGOH | Protein mago nashi homolog | 0.764 | Q92769 | HDAC2 | Histone deacetylase 2 | P61326 | MAGOH | Protein mago nashi homolog | 0.812 | P49768 | PSEN1 | Presenilin-1 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | 0.808 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9GZY0 | NXF2; NXF2B | Nuclear RNA export factor 2 | 0.746 | P49768 | PSEN1 | Presenilin-1 | P37198 | NUP62 | Nuclear pore glycoprotein p62 | -0.716 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.883 | Q92769 | HDAC2 | Histone deacetylase 2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.775 | P08246 | ELA2 | Neutrophil elastase | Q7Z3B4 | NUP54 | Nucleoporin p54 | -0.723 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.708 | P49768 | PSEN1 | Presenilin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.768 | Q92769 | HDAC2 | Histone deacetylase 2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.729 | P08246 | ELA2 | Neutrophil elastase | P35658 | NUP214 | Nuclear pore complex protein Nup214 | 0.765 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.844 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.869 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.707 | Q92769 | HDAC2 | Histone deacetylase 2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.719 | P08246 | ELA2 | Neutrophil elastase | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | -0.722 | P49768 | PSEN1 | Presenilin-1 | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.71 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.77 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.788 | P08246 | ELA2 | Neutrophil elastase | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | -0.825 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.869 | P08246 | ELA2 | Neutrophil elastase | P78345 | RPP38 | Ribonuclease P protein subunit p38 | -0.795 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.849 | Q92769 | HDAC2 | Histone deacetylase 2 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.79 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.764 | Q92769 | HDAC2 | Histone deacetylase 2 | P23588 | EIF4B | Eukaryotic translation initiation factor 4B | 0.767 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.815 | Q92769 | HDAC2 | Histone deacetylase 2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.758 | P08246 | ELA2 | Neutrophil elastase | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | 0.849 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.863 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.798 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q53GS7 | GLE1 | mRNA export factor GLE1 | -0.723 |
| Sacubitril | hsa03015 | mRNA surveillance pathway | 9.78E-03 | 6 | O43148, Q16537, P61326, Q9GZY0, P52298, Q53GS7 | RNMT, PPP2R5E, MAGOH, NXF2; NXF2B, NCBP2, GLE1 | More | | Sacubitril | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Sacubitril | hsa03030 | DNA replication | 1.48E-02 | 3 | P49005, P33993, P15927 | POLD2, MCM7, RPA2 | More | | Sacubitril | hsa03040 | Spliceosome | 4.19E-04 | 10 | Q14562, O43143, O60508, P08579, Q07955, Q01130, Q13243, P11142, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, SFRS1, SFRS2, SFRS5, HSPA8, PPIH, ASCC3L1 | More | | Sacubitril | hsa03060 | Protein export | 1.90E-02 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Sacubitril | hsa04012 | ErbB signaling pathway | 1.34E-02 | 4 | P16333, P19174, P42338, P01106 | NCK1, PLCG1, PIK3CB, MYC | More | | Sacubitril | hsa04014 | Ras signaling pathway | 2.92E-04 | 10 | P42338, P20827, Q9NRA1, P49767, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PIK3CB, EFNA1, PDGFC, VEGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Sacubitril | hsa04015 | Rap1 signaling pathway | 4.69E-04 | 11 | P20827, Q9NRA1, P49767, P11215, P25116, Q8TEU7, Q13009, P42338, P0DP23, P08514, P19174 | EFNA1, PDGFC, VEGFC, ITGAM, F2R, RAPGEF6, TIAM1, PIK3CB, CALM1, ITGA2B, PLCG1 | More | | Sacubitril | hsa04020 | Calcium signaling pathway | 8.05E-05 | 13 | P27987, Q96DU7, P21796, Q13557, P21860, P19174, P0DP23, P05141, P12236, P26678, P63092, Q9NRA1, P49767 | ITPKB, ITPKC, VDAC1, CAMK2D, ERBB3, PLCG1, CALM1, SLC25A5, SLC25A6, PLN, GNAS, PDGFC, VEGFC | More | | Sacubitril | hsa04022 | cGMP-PKG signaling pathway | 2.71E-04 | 9 | P24844, P61586, P26678, Q99941, P18848, Q8WYR1, P05141, P12236, Q15746 | MYL9, RHOA, PLN, CREBL1, ATF4, PIK3R5, SLC25A5, SLC25A6, MYLK | More | | Sacubitril | hsa04024 | cAMP signaling pathway | 1.40E-02 | 3 | P48058, P25116, P24844 | GRIA4, F2R, MYL9 | More | | Sacubitril | hsa04060 | Cytokine-cytokine receptor interaction | 5.39E-03 | 10 | P27930, P08476, Q13651, Q9HBE5, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, IL10RA, IL21R, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Sacubitril | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.81E-03 | 9 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Sacubitril | hsa04062 | Chemokine signaling pathway | 2.81E-05 | 15 | P25024, P25025, P09341, P19875, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q13009, P14598, P42224, P25963 | CXCR1, CXCR2, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, TIAM1, NCF1, STAT1, NFKBIA | More | | Sacubitril | hsa04064 | NF-kappa B signaling pathway | 2.46E-13 | 19 | P10415, Q13489, P25963, P51617, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, Q13315, P24522, P09341, P19875, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, ATM, GADD45A, CXCL1, CXCL2, LTB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | P24158 | PRTN3 | Myeloblastin | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.787 | P22894 | MMP8 | Neutrophil collagenase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.959 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P22894 | MMP8 | Neutrophil collagenase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.765 | P08246 | ELA2 | Neutrophil elastase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.832 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P22894 | MMP8 | Neutrophil collagenase | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.744 | P08246 | ELA2 | Neutrophil elastase | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.734 | P06737 | PYGL | Glycogen phosphorylase, liver form | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.924 | P24158 | PRTN3 | Myeloblastin | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.8 | P22894 | MMP8 | Neutrophil collagenase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.867 | P08246 | ELA2 | Neutrophil elastase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.814 | P08311 | CTSG | Cathepsin G | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P22894 | MMP8 | Neutrophil collagenase | P01375 | TNF | Tumor necrosis factor | 0.728 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P24158 | PRTN3 | Myeloblastin | Q04759 | PRKCQ | Protein kinase C theta type | -0.845 | P22894 | MMP8 | Neutrophil collagenase | Q04759 | PRKCQ | Protein kinase C theta type | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08246 | ELA2 | Neutrophil elastase | Q04759 | PRKCQ | Protein kinase C theta type | -0.748 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P24158 | PRTN3 | Myeloblastin | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.733 | P22894 | MMP8 | Neutrophil collagenase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.891 | P08246 | ELA2 | Neutrophil elastase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.783 | P22894 | MMP8 | Neutrophil collagenase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.806 | P08246 | ELA2 | Neutrophil elastase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.725 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.967 | P24158 | PRTN3 | Myeloblastin | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.802 | P22894 | MMP8 | Neutrophil collagenase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.843 | P08246 | ELA2 | Neutrophil elastase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.766 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.751 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q8WV28 | BLNK | B-cell linker protein | -0.706 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q8WV28 | BLNK | B-cell linker protein | -0.746 | P08246 | ELA2 | Neutrophil elastase | Q13315 | ATM | Serine-protein kinase ATM | -0.742 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P06737 | PYGL | Glycogen phosphorylase, liver form | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.822 | P24158 | PRTN3 | Myeloblastin | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.772 | P22894 | MMP8 | Neutrophil collagenase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.766 | P08246 | ELA2 | Neutrophil elastase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.7 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09341 | CXCL1 | Growth-regulated alpha protein | 0.74 | P24158 | PRTN3 | Myeloblastin | P09341 | CXCL1 | Growth-regulated alpha protein | 0.751 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | P08311 | CTSG | Cathepsin G | P09341 | CXCL1 | Growth-regulated alpha protein | 0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 |
| Sacubitril | hsa04070 | Phosphatidylinositol signaling system | 1.12E-02 | 5 | P19174, P0DP23, P42338, P23743, P27987 | PLCG1, CALM1, PIK3CB, DGKA, ITPKB | More | | Sacubitril | hsa04071 | Sphingolipid signaling pathway | 3.24E-15 | 13 | P17252, P21453, Q9H228, P01375, Q13510, Q13362, Q16537, Q9BX95, Q16539, P04637, P10415, Q9UQC2, P01042 | PRKCA, S1PR1, EDG8, TNF, ASAH1, PPP2R5C, PPP2R5E, SGPP1, MAPK14, TP53, BCL2, GAB2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P17252 | PRKCA | Protein kinase C alpha type | 0.807 | P22894 | MMP8 | Neutrophil collagenase | P17252 | PRKCA | Protein kinase C alpha type | -0.759 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P17252 | PRKCA | Protein kinase C alpha type | -0.757 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P24158 | PRTN3 | Myeloblastin | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.82 | P22894 | MMP8 | Neutrophil collagenase | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.721 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.832 | P08246 | ELA2 | Neutrophil elastase | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.725 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.934 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.841 | P24158 | PRTN3 | Myeloblastin | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.904 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.901 | P22894 | MMP8 | Neutrophil collagenase | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.787 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.733 | P08246 | ELA2 | Neutrophil elastase | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.797 | P15144 | ANPEP | Aminopeptidase N | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.777 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P22894 | MMP8 | Neutrophil collagenase | P01375 | TNF | Tumor necrosis factor | 0.728 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P15144 | ANPEP | Aminopeptidase N | P01375 | TNF | Tumor necrosis factor | 0.878 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13510 | ASAH1 | Acid ceramidase | 0.748 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.716 | P24158 | PRTN3 | Myeloblastin | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.756 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.828 | P22894 | MMP8 | Neutrophil collagenase | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.834 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.773 | P08246 | ELA2 | Neutrophil elastase | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.865 | P15144 | ANPEP | Aminopeptidase N | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.721 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.733 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q16537 | PPP2R5E | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform | 0.718 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.781 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | 0.884 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.869 | P22894 | MMP8 | Neutrophil collagenase | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.879 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.884 | P08246 | ELA2 | Neutrophil elastase | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.847 | P15144 | ANPEP | Aminopeptidase N | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | 0.7 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.721 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.708 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P04637 | TP53 | Cellular tumor antigen p53 | 0.753 | P06737 | PYGL | Glycogen phosphorylase, liver form | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | P24158 | PRTN3 | Myeloblastin | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.787 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.859 | P14780 | MMP9 | Matrix metalloproteinase-9 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.765 | P22894 | MMP8 | Neutrophil collagenase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.959 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.865 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.706 | P15144 | ANPEP | Aminopeptidase N | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.729 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.822 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.708 | P15144 | ANPEP | Aminopeptidase N | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.783 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.894 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P01042 | KNG1 | Kininogen-1 | -0.773 |
| Sacubitril | hsa04072 | Phospholipase D signaling pathway | 1.10E-03 | 11 | P42338, Q9UQC2, P43657, P25024, P25025, P19174, Q14344, Q8WYR1, Q08828, P23743, Q9NRA1 | PIK3CB, GAB2, P2RY5, CXCR1, CXCR2, PLCG1, GNA13, PIK3R5, ADCY1, DGKA, PDGFC | More | | Sacubitril | hsa04080 | Neuroactive ligand-receptor interaction | 1.40E-09 | 14 | P08311, P00734, Q15722, P21453, Q9H228, O00398, Q96G91, P25116, P21462, P21730, Q16581, P07550, P01042, P35318 | CTSG, F2, LTB4R, S1PR1, EDG8, P2RY10, P2RY11, F2R, FPR1, C5AR1, C3AR1, ADRB2, KNG1, ADM | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | P08311 | CTSG | Cathepsin G | 0.829 | P24158 | PRTN3 | Myeloblastin | P08311 | CTSG | Cathepsin G | 0.914 | P22894 | MMP8 | Neutrophil collagenase | P08311 | CTSG | Cathepsin G | 0.8 | P08246 | ELA2 | Neutrophil elastase | P08311 | CTSG | Cathepsin G | 0.792 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08311 | CTSG | Cathepsin G | -0.811 | P43005 | SLC1A1 | Excitatory amino acid transporter 3 | P00734 | F2 | Prothrombin | 0.702 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15722 | LTB4R | Leukotriene B4 receptor 1 | 0.863 | P24158 | PRTN3 | Myeloblastin | Q15722 | LTB4R | Leukotriene B4 receptor 1 | 0.829 | P22894 | MMP8 | Neutrophil collagenase | Q15722 | LTB4R | Leukotriene B4 receptor 1 | 0.882 | P08246 | ELA2 | Neutrophil elastase | Q15722 | LTB4R | Leukotriene B4 receptor 1 | 0.846 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | -0.891 | P24158 | PRTN3 | Myeloblastin | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.82 | P22894 | MMP8 | Neutrophil collagenase | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.721 | P08246 | ELA2 | Neutrophil elastase | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | -0.725 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.934 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.841 | P24158 | PRTN3 | Myeloblastin | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.904 | P22894 | MMP8 | Neutrophil collagenase | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.787 | P08246 | ELA2 | Neutrophil elastase | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.797 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.777 | P24158 | PRTN3 | Myeloblastin | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | -0.707 | P22894 | MMP8 | Neutrophil collagenase | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | -0.831 | P08246 | ELA2 | Neutrophil elastase | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | -0.793 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | -0.786 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | 0.704 | P43005 | SLC1A1 | Excitatory amino acid transporter 3 | Q96G91 | P2RY11 | P2Y purinoceptor 11 | 0.765 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P25116 | F2R | Proteinase-activated receptor 1 | -0.791 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.833 | P24158 | PRTN3 | Myeloblastin | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.73 | P22894 | MMP8 | Neutrophil collagenase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.88 | P08246 | ELA2 | Neutrophil elastase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.85 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.888 | P24158 | PRTN3 | Myeloblastin | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.738 | P22894 | MMP8 | Neutrophil collagenase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.756 | P08246 | ELA2 | Neutrophil elastase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.703 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.772 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | 0.808 | P24158 | PRTN3 | Myeloblastin | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | 0.753 | P22894 | MMP8 | Neutrophil collagenase | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | 0.746 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P07550 | ADRB2 | Beta-2 adrenergic receptor | 0.735 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P01042 | KNG1 | Kininogen-1 | -0.773 | P06737 | PYGL | Glycogen phosphorylase, liver form | P35318 | ADM | Pro-adrenomedullin [Cleaved into: Adrenomedullin | 0.727 |
| Sacubitril | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Sacubitril | hsa04120 | Ubiquitin mediated proteolysis | 2.51E-03 | 6 | Q14145, Q13042, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, UBE2D2, HERC1, UBR5, UBB | More | | Sacubitril | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Sacubitril | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Sacubitril | hsa04140 | Autophagy - animal | 3.94E-03 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Sacubitril | hsa04144 | Endocytosis | 4.10E-02 | 3 | O75351, P62491, Q14161 | VPS4B, RAB11A, GIT2 | More | | Sacubitril | hsa04145 | Phagosome | 2.08E-09 | 12 | O75015, P63261, Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765 | FCGR3B, ACTG1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Sacubitril | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Sacubitril | hsa04151 | PI3K-Akt signaling pathway | 3.37E-05 | 26 | P42338, P21860, P01106, O43521, P27348, P20827, O14944, Q9NRA1, P49767, Q13362, P07900, P08238, Q15831, Q8WYR1, P62873, P63218, P50151, O15335, P22105, P14784, P23458, P01568, Q99941, P18848, Q6ZUJ8, O95988 | PIK3CB, ERBB3, MYC, BCL2L11, YWHAQ, EFNA1, EREG, PDGFC, VEGFC, PPP2R5C, HSP90AA1, HSP90AB1, STK11, PIK3R5, GNB1, GNG5, GNG10, CHAD, TNXB, IL2RB, JAK1, IFNA21, CREBL1, ATF4, PIK3AP1, TCL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | -0.731 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P42892 | ECE1 | Endothelin-converting enzyme 1 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.736 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P27348 | YWHAQ | 14-3-3 protein theta | 0.711 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P20827 | EFNA1 | Ephrin-A1 | -0.743 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O14944 | EREG | Proepiregulin [Cleaved into: Epiregulin | -0.778 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.733 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.718 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | 0.731 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.725 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O15335 | CHAD | Chondroadherin | -0.704 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P22105 | TNXB | Tenascin-X | 0.802 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.797 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.802 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.781 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.747 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O95988 | TCL1B | T-cell leukemia/lymphoma protein 1B | 0.719 |
| Sacubitril | hsa04210 | Apoptosis | 1.26E-04 | 12 | Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, P18848, Q14643 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ATF4, ITPR1 | More | | Sacubitril | hsa04213 | Longevity regulating pathway - multiple species | 1.36E-03 | 6 | P42338, Q9Y4H2, Q08828, P0DMV8, P11142, Q13547 | PIK3CB, IRS2, ADCY1, HSPA1A, HSPA8, HDAC1 | More | | Sacubitril | hsa04215 | Apoptosis - multiple species | 3.01E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Sacubitril | hsa04217 | Necroptosis | 2.24E-04 | 12 | P01375, P01568, P48023, Q13489, P42224, Q14765, P08238, Q6FI13, Q99878, Q93077, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, HIST1H2AC, CHMP2A, PPID | More | | Sacubitril | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.12E-02 | 5 | P63092, Q99941, P18848, P26678, Q13557 | GNAS, CREBL1, ATF4, PLN, CAMK2D | More | | Sacubitril | hsa04270 | Vascular smooth muscle contraction | 2.56E-03 | 5 | Q15746, P24844, Q08828, P35579, P35318 | MYLK, MYL9, ADCY1, MYH9, ADM | More | | Sacubitril | hsa04330 | Notch signaling pathway | 2.77E-02 | 2 | Q92542, P49768 | NCSTN, PSEN1 | More | | Sacubitril | hsa04340 | Hedgehog signaling pathway | 5.20E-07 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Sacubitril | hsa04360 | Axon guidance | 1.90E-03 | 7 | P16333, P20827, O95631, P42338, P23528, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, CFL1, PLCG1, PTPN11 | More | | Sacubitril | hsa04371 | Apelin signaling pathway | 2.41E-03 | 7 | P62873, P63218, P50151, Q13370, Q14814, Q14344, P0DP23 | GNB1, GNG5, GNG10, PDE3B, MEF2D, GNA13, CALM1 | More | | Sacubitril | hsa04380 | Osteoclast differentiation | 1.81E-02 | 4 | Q9UQC2, Q16539, Q8WV28, Q15080 | GAB2, MAPK14, BLNK, NCF4 | More | | Sacubitril | hsa04390 | Hippo signaling pathway | 2.30E-02 | 3 | P63261, P04628, O43623 | ACTG1, WNT1, SNAI2 | More | | Sacubitril | hsa04510 | Focal adhesion | 4.41E-03 | 7 | P16144, P08514, Q15746, P24844, Q15942, Q13489, P10415 | ITGB4, ITGA2B, MYLK, MYL9, ZYX, BIRC3, BCL2 | More | | Sacubitril | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Sacubitril | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Sacubitril | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Sacubitril | hsa04540 | Gap junction | 3.53E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Sacubitril | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.96E-02 | 3 | P04628, P40189, P14653 | WNT1, IL6ST, HOXB1 | More | | Sacubitril | hsa04610 | Complement and coagulation cascades | 3.36E-10 | 7 | P25116, P01042, P00734, P0C0L4, P10909, P05107, Q16581 | F2R, KNG1, F2, C4A, CLU, ITGB2, C3AR1 | More | | Sacubitril | hsa04611 | Platelet activation | 1.55E-06 | 7 | P25116, Q9Y490, P08514, Q15746, Q08828, Q8WYR1, P07359 | F2R, TLN1, ITGA2B, MYLK, ADCY1, PIK3R5, GP1BA | More | | Sacubitril | hsa04612 | Antigen processing and presentation | 3.57E-06 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Sacubitril | hsa04613 | Neutrophil extracellular trap formation | 1.14E-12 | 24 | P42338, P19174, P17252, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, P62807, Q93079, P21796, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, P63261, O43315, Q16539 | PIK3CB, PLCG1, PRKCA, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, HIST1H2BC, H2BC9, VDAC1, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, ACTG1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P17252 | PRKCA | Protein kinase C alpha type | 0.807 | P22894 | MMP8 | Neutrophil collagenase | P17252 | PRKCA | Protein kinase C alpha type | -0.759 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P17252 | PRKCA | Protein kinase C alpha type | -0.757 | P08246 | ELA2 | Neutrophil elastase | P17252 | PRKCA | Protein kinase C alpha type | -0.735 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P11215 | ITGAM | Integrin alpha-M | -0.877 | P06737 | PYGL | Glycogen phosphorylase, liver form | O60603 | TLR2 | Toll-like receptor 2 | 0.836 | P24158 | PRTN3 | Myeloblastin | O60603 | TLR2 | Toll-like receptor 2 | 0.729 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O60603 | TLR2 | Toll-like receptor 2 | -0.797 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P22894 | MMP8 | Neutrophil collagenase | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.942 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P06737 | PYGL | Glycogen phosphorylase, liver form | P05164 | MPO | Myeloperoxidase | 0.858 | P24158 | PRTN3 | Myeloblastin | P05164 | MPO | Myeloperoxidase | 0.979 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P05164 | MPO | Myeloperoxidase | -0.754 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P22894 | MMP8 | Neutrophil collagenase | P05164 | MPO | Myeloperoxidase | 0.905 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P05164 | MPO | Myeloperoxidase | 0.805 | P08246 | ELA2 | Neutrophil elastase | P05164 | MPO | Myeloperoxidase | 0.903 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08246 | ELA2 | Neutrophil elastase | 0.817 | P24158 | PRTN3 | Myeloblastin | P08246 | ELA2 | Neutrophil elastase | 0.894 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P08246 | ELA2 | Neutrophil elastase | -0.833 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P22894 | MMP8 | Neutrophil collagenase | P08246 | ELA2 | Neutrophil elastase | 0.985 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.846 | P08246 | ELA2 | Neutrophil elastase | P08246 | ELA2 | Neutrophil elastase | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.813 | P24158 | PRTN3 | Myeloblastin | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.873 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.771 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.9 | P22894 | MMP8 | Neutrophil collagenase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.877 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.799 | P08246 | ELA2 | Neutrophil elastase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.889 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.819 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | P24158 | PRTN3 | Myeloblastin | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.713 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.859 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.74 | P22894 | MMP8 | Neutrophil collagenase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.909 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.833 | P08246 | ELA2 | Neutrophil elastase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.907 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.703 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.703 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q93079 | H2BC9 | Histone H2B type 1-H | 0.756 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P21796 | VDAC1 | Voltage-dependent anion-selective channel protein 1 | 0.72 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.708 | P22894 | MMP8 | Neutrophil collagenase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.74 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.755 | P08246 | ELA2 | Neutrophil elastase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.762 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.836 | P24158 | PRTN3 | Myeloblastin | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.815 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.89 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | P22894 | MMP8 | Neutrophil collagenase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.963 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.918 | P08246 | ELA2 | Neutrophil elastase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.945 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.731 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20160 | AZU1 | Azurocidin | 0.781 | P24158 | PRTN3 | Myeloblastin | P20160 | AZU1 | Azurocidin | 0.942 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20160 | AZU1 | Azurocidin | 0.734 | P22894 | MMP8 | Neutrophil collagenase | P20160 | AZU1 | Azurocidin | 0.824 | P08246 | ELA2 | Neutrophil elastase | P20160 | AZU1 | Azurocidin | 0.842 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20160 | AZU1 | Azurocidin | -0.799 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08311 | CTSG | Cathepsin G | 0.829 | P24158 | PRTN3 | Myeloblastin | P08311 | CTSG | Cathepsin G | 0.914 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | P22894 | MMP8 | Neutrophil collagenase | P08311 | CTSG | Cathepsin G | 0.8 | P08246 | ELA2 | Neutrophil elastase | P08311 | CTSG | Cathepsin G | 0.792 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08311 | CTSG | Cathepsin G | -0.811 | P22894 | MMP8 | Neutrophil collagenase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.7 | P08246 | ELA2 | Neutrophil elastase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.807 | P06737 | PYGL | Glycogen phosphorylase, liver form | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.852 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | P22894 | MMP8 | Neutrophil collagenase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.734 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.737 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.888 | P24158 | PRTN3 | Myeloblastin | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.738 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.942 | P22894 | MMP8 | Neutrophil collagenase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.756 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.875 | P08246 | ELA2 | Neutrophil elastase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.703 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.772 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.833 | P24158 | PRTN3 | Myeloblastin | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.73 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.723 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.912 | P22894 | MMP8 | Neutrophil collagenase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.88 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.888 | P08246 | ELA2 | Neutrophil elastase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.85 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.719 | P06737 | PYGL | Glycogen phosphorylase, liver form | O43315 | AQP9 | Aquaporin-9 | 0.897 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43315 | AQP9 | Aquaporin-9 | 0.837 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O43315 | AQP9 | Aquaporin-9 | 0.79 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.721 |
| Sacubitril | hsa04620 | Toll-like receptor signaling pathway | 4.00E-02 | 4 | P01568, P42224, P25963, P42338 | IFNA21, STAT1, NFKBIA, PIK3CB | More | | Sacubitril | hsa04621 | NOD-like receptor signaling pathway | 2.29E-06 | 16 | Q16539, Q14643, P23458, P25963, Q9H3M7, Q13489, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P49913, P12838 | MAPK14, ITPR1, JAK1, NFKBIA, TXNIP, BIRC3, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, CAMP, DEFA4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.804 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.81 | P08246 | ELA2 | Neutrophil elastase | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.816 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.797 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q9H3M7 | TXNIP | Thioredoxin-interacting protein | 0.747 | P08246 | ELA2 | Neutrophil elastase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | P06737 | PYGL | Glycogen phosphorylase, liver form | P10599 | TXN | Thioredoxin | 0.764 | P14780 | MMP9 | Matrix metalloproteinase-9 | P10599 | TXN | Thioredoxin | 0.713 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9H1Y0 | ATG5 | Autophagy protein 5 | -0.73 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9H1Y0 | ATG5 | Autophagy protein 5 | -0.895 | P08246 | ELA2 | Neutrophil elastase | Q9H1Y0 | ATG5 | Autophagy protein 5 | -0.759 | P06737 | PYGL | Glycogen phosphorylase, liver form | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.912 | P14780 | MMP9 | Matrix metalloproteinase-9 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.94 | P08246 | ELA2 | Neutrophil elastase | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.702 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.815 | P06737 | PYGL | Glycogen phosphorylase, liver form | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.924 | P14780 | MMP9 | Matrix metalloproteinase-9 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.917 | P08246 | ELA2 | Neutrophil elastase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.814 | P06737 | PYGL | Glycogen phosphorylase, liver form | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | P14780 | MMP9 | Matrix metalloproteinase-9 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.765 | P08246 | ELA2 | Neutrophil elastase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.942 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q05823 | RNASEL | 2-5A-dependent ribonuclease | 0.73 | P08246 | ELA2 | Neutrophil elastase | Q05823 | RNASEL | 2-5A-dependent ribonuclease | 0.734 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09341 | CXCL1 | Growth-regulated alpha protein | 0.74 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.771 | P08246 | ELA2 | Neutrophil elastase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.807 | P06737 | PYGL | Glycogen phosphorylase, liver form | P12838 | DEFA4 | Neutrophil defensin 4 | 0.7 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | P08246 | ELA2 | Neutrophil elastase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.709 |
| Sacubitril | hsa04622 | RIG-I-like receptor signaling pathway | 1.36E-02 | 2 | Q12933, P10145 | TRAF2, IL8 | More | | Sacubitril | hsa04623 | Cytosolic DNA-sensing pathway | 1.85E-03 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Sacubitril | hsa04625 | C-type lectin receptor signaling pathway | 2.17E-02 | 5 | Q9ULY5, P42224, P25963, P42338, P0DP23 | CLEC4E, STAT1, NFKBIA, PIK3CB, CALM1 | More | | Sacubitril | hsa04630 | JAK-STAT signaling pathway | 4.43E-02 | 3 | P48551, P40189, Q06124 | IFNAR2, IL6ST, PTPN11 | More | | Sacubitril | hsa04640 | Hematopoietic cell lineage | 2.01E-03 | 10 | P14778, P27930, P11215, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Sacubitril | hsa04650 | Natural killer cell mediated cytotoxicity | 1.91E-08 | 11 | P19174, P01375, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, P26717, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, KLRC2, KLRC1 | More | | Sacubitril | hsa04657 | IL-17 signaling pathway | 8.22E-05 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Sacubitril | hsa04658 | Th1 and Th2 cell differentiation | 5.71E-15 | 16 | P25963, Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, P42224, Q14765, P42226, P23771, Q9UL17, P14784, P13765, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT1, STAT4, STAT6, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | P13612 | ITGA4 | Integrin alpha-4 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.729 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | P13612 | ITGA4 | Integrin alpha-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.768 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | P13612 | ITGA4 | Integrin alpha-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.85 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P13612 | ITGA4 | Integrin alpha-4 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.732 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.736 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P06737 | PYGL | Glycogen phosphorylase, liver form | P42226 | STAT6 | Signal transducer and activator of transcription 6 | 0.852 | P06737 | PYGL | Glycogen phosphorylase, liver form | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.753 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | P13612 | ITGA4 | Integrin alpha-4 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.764 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.738 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | P13612 | ITGA4 | Integrin alpha-4 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.822 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P06737 | PYGL | Glycogen phosphorylase, liver form | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.845 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.804 | P13612 | ITGA4 | Integrin alpha-4 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.78 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 |
| Sacubitril | hsa04659 | Th17 cell differentiation | 2.33E-08 | 17 | P25963, Q04759, Q16539, P19174, P06239, P42224, P42226, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, LCK, STAT1, STAT6, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P06737 | PYGL | Glycogen phosphorylase, liver form | P42226 | STAT6 | Signal transducer and activator of transcription 6 | 0.852 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P06737 | PYGL | Glycogen phosphorylase, liver form | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.845 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.738 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06737 | PYGL | Glycogen phosphorylase, liver form | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.753 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Sacubitril | hsa04660 | T cell receptor signaling pathway | 6.51E-12 | 17 | P01375, P25963, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, NFKBIA, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | P08246 | ELA2 | Neutrophil elastase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P08246 | ELA2 | Neutrophil elastase | Q04759 | PRKCQ | Protein kinase C theta type | -0.748 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P08246 | ELA2 | Neutrophil elastase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.854 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P06737 | PYGL | Glycogen phosphorylase, liver form | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.73 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | P13612 | ITGA4 | Integrin alpha-4 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.834 | P08246 | ELA2 | Neutrophil elastase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.724 | P08311 | CTSG | Cathepsin G | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.705 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.8 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | P13612 | ITGA4 | Integrin alpha-4 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | P08246 | ELA2 | Neutrophil elastase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.782 | P08311 | CTSG | Cathepsin G | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P13612 | ITGA4 | Integrin alpha-4 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.729 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | P13612 | ITGA4 | Integrin alpha-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.768 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | P13612 | ITGA4 | Integrin alpha-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.85 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.72 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | P13612 | ITGA4 | Integrin alpha-4 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | P13612 | ITGA4 | Integrin alpha-4 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.83 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P13612 | ITGA4 | Integrin alpha-4 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.732 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P06737 | PYGL | Glycogen phosphorylase, liver form | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.815 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 |
| Sacubitril | hsa04662 | B cell receptor signaling pathway | 1.12E-02 | 5 | P25963, P42338, P07948, P21854, Q8N149 | NFKBIA, PIK3CB, LYN, CD72, LILRA2 | More | | Sacubitril | hsa04664 | Fc epsilon RI signaling pathway | 1.74E-03 | 6 | P42338, Q9UQC2, P07948, P19174, P09917, P20292 | PIK3CB, GAB2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Sacubitril | hsa04666 | Fc gamma R-mediated phagocytosis | 7.22E-05 | 10 | O75015, P07948, P42338, P19174, P23528, P49006, P06396, O14494, P14598, P17252 | FCGR3B, LYN, PIK3CB, PLCG1, CFL1, MARCKSL1, GSN, PLPP1, NCF1, PRKCA | More | | Sacubitril | hsa04668 | TNF signaling pathway | 2.59E-02 | 7 | P01375, O00463, Q13489, P25963, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, NFKBIA, BCL3, TRAF1, MMP9 | More | | Sacubitril | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Sacubitril | hsa04713 | Circadian entrainment | 4.00E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Sacubitril | hsa04721 | Synaptic vesicle cycle | 3.15E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Sacubitril | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Sacubitril | hsa04723 | Retrograde endocannabinoid signaling | 1.75E-02 | 5 | Q14643, P17252, P22694, Q16539, Q16718 | ITPR1, PRKCA, PRKACB, MAPK14, NDUFA5 | More | | Sacubitril | hsa04724 | Glutamatergic synapse | 3.15E-03 | 6 | P48058, P62873, P63218, P50151, P15104, Q9NSB8 | GRIA4, GNB1, GNG5, GNG10, GLUL, HOMER2 | More | | Sacubitril | hsa04725 | Cholinergic synapse | 2.78E-03 | 8 | P22694, Q14643, P62873, P63218, P50151, P18848, P42338, P10415 | PRKACB, ITPR1, GNB1, GNG5, GNG10, ATF4, PIK3CB, BCL2 | More | | Sacubitril | hsa04727 | GABAergic synapse | 8.14E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Sacubitril | hsa04744 | Phototransduction | 1.32E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Sacubitril | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.12E-04 | 6 | P14778, P19174, P42338, P24723, Q04759, P0DP23 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1 | More | | Sacubitril | hsa04810 | Regulation of actin cytoskeleton | 4.38E-04 | 10 | P12814, P24844, Q15746, Q13009, P42338, P08514, P11215, Q14344, Q9NRA1, P25116 | ACTN1, MYL9, MYLK, TIAM1, PIK3CB, ITGA2B, ITGAM, GNA13, PDGFC, F2R | More | | Sacubitril | hsa04911 | Insulin secretion | 4.47E-03 | 4 | P63092, Q99941, P18848, Q13557 | GNAS, CREBL1, ATF4, CAMK2D | More | | Sacubitril | hsa04912 | GnRH signaling pathway | 3.14E-03 | 5 | P17252, Q16539, Q9Y6R4, Q14643, P22694 | PRKCA, MAPK14, MAP3K4, ITPR1, PRKACB | More | | Sacubitril | hsa04914 | Progesterone-mediated oocyte maturation | 4.00E-02 | 4 | P42338, Q13370, P30304, P08238 | PIK3CB, PDE3B, CDC25A, HSP90AB1 | More | | Sacubitril | hsa04915 | Estrogen signaling pathway | 2.07E-03 | 8 | P14780, P22694, P18848, Q08828, P0DMV8, Q14643, Q15788, P10415 | MMP9, PRKACB, ATF4, ADCY1, HSPA1A, ITPR1, NCOA1, BCL2 | More | | Sacubitril | hsa04918 | Thyroid hormone synthesis | 2.91E-02 | 3 | P22694, P18848, Q14643 | PRKACB, ATF4, ITPR1 | More | | Sacubitril | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Sacubitril | hsa04921 | Oxytocin signaling pathway | 6.84E-04 | 5 | Q15746, Q08828, P24844, Q96RR4, Q8WYR1 | MYLK, ADCY1, MYL9, CAMKK2, PIK3R5 | More | | Sacubitril | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Sacubitril | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Sacubitril | hsa04924 | Renin secretion | 8.55E-04 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Sacubitril | hsa04925 | Aldosterone synthesis and secretion | 1.68E-02 | 4 | Q99941, P18848, P63092, Q13557 | CREBL1, ATF4, GNAS, CAMK2D | More | | Sacubitril | hsa04926 | Relaxin signaling pathway | 8.74E-03 | 6 | P25963, P42338, P62873, P63218, P50151, P49767 | NFKBIA, PIK3CB, GNB1, GNG5, GNG10, VEGFC | More | | Sacubitril | hsa04927 | Cortisol synthesis and secretion | 5.54E-04 | 5 | Q14643, Q99941, P18848, P63092, P22694 | ITPR1, CREBL1, ATF4, GNAS, PRKACB | More | | Sacubitril | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.60E-05 | 9 | Q14643, P63092, P22694, P23771, P17252, P61586, Q99941, P18848, P10415 | ITPR1, GNAS, PRKACB, GATA3, PRKCA, RHOA, CREBL1, ATF4, BCL2 | More | | Sacubitril | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Sacubitril | hsa04934 | Cushing syndrome | 1.37E-03 | 5 | Q99941, P18848, P63092, O15169, Q13557 | CREBL1, ATF4, GNAS, AXIN1, CAMK2D | More | | Sacubitril | hsa04940 | Type I diabetes mellitus | 2.61E-03 | 4 | P10747, P48023, P13765, P01375 | CD28, FASLG, HLA-DOB, TNF | More | | Sacubitril | hsa04950 | Maturity onset diabetes of the young | 4.70E-02 | 1 | P35557 | GCK | More | | Sacubitril | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Sacubitril | hsa04964 | Proximal tubule bicarbonate reclamation | 2.74E-03 | 3 | P22748, P00918, P49448 | CA4, CA2, GLUD2 | More | | Sacubitril | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Sacubitril | hsa04970 | Salivary secretion | 4.49E-02 | 4 | P22694, Q14643, P17252, P49913 | PRKACB, ITPR1, PRKCA, CAMP | More | | Sacubitril | hsa04972 | Pancreatic secretion | 4.89E-03 | 5 | Q14643, P20020, P17252, Q08828, P62491 | ITPR1, ATP2B1, PRKCA, ADCY1, RAB11A | More | | Sacubitril | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Sacubitril | hsa05010 | Alzheimer disease | 1.36E-02 | 9 | Q92542, O15239, P05496, P18848, O15169, P05141, P12236, P43686, P62195 | NCSTN, NDUFA1, ATP5G1, ATF4, AXIN1, SLC25A5, SLC25A6, PSMC4, PSMC5 | More | | Sacubitril | hsa05012 | Parkinson disease | 5.04E-04 | 15 | O15239, P05496, P05141, P12236, P21796, P60604, P63092, P18848, P43686, P62195, P19174, P0DP23, Q13557, Q71U36, Q13509 | NDUFA1, ATP5G1, SLC25A5, SLC25A6, VDAC1, UBE2G2, GNAS, ATF4, PSMC4, PSMC5, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Sacubitril | hsa05014 | Amyotrophic lateral sclerosis | 3.98E-03 | 17 | P01375, P20333, O15239, Q16718, O14521, P36542, P05496, P18848, P43686, P62195, P51991, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, TNFRSF1B, NDUFA1, NDUFA5, SDHD, ATP5C1, ATP5G1, ATF4, PSMC4, PSMC5, HNRPA3, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Sacubitril | hsa05020 | Prion disease | 1.15E-02 | 9 | P46531, O15239, P05496, P18848, P05141, P12236, P43686, P62195, Q99941 | NOTCH1, NDUFA1, ATP5G1, ATF4, SLC25A5, SLC25A6, PSMC4, PSMC5, CREBL1 | More | | Sacubitril | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.57E-02 | 10 | O15239, P05496, P18848, P05141, P12236, P20333, O15169, Q13557, P43686, P62195 | NDUFA1, ATP5G1, ATF4, SLC25A5, SLC25A6, TNFRSF1B, AXIN1, CAMK2D, PSMC4, PSMC5 | More | | Sacubitril | hsa05030 | Cocaine addiction | 2.40E-02 | 3 | P63092, Q99941, P18848 | GNAS, CREBL1, ATF4 | More | | Sacubitril | hsa05031 | Amphetamine addiction | 4.47E-03 | 4 | Q13557, P63092, Q99941, P18848 | CAMK2D, GNAS, CREBL1, ATF4 | More | | Sacubitril | hsa05032 | Morphine addiction | 7.60E-03 | 5 | P62873, P63218, P50151, Q13370, P43250 | GNB1, GNG5, GNG10, PDE3B, GRK6 | More | | Sacubitril | hsa05034 | Alcoholism | 6.32E-03 | 7 | Q13547, P0DP23, P62873, P63218, P50151, P62807, Q93079 | HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2BC, H2BC9 | More | | Sacubitril | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Sacubitril | hsa05130 | Pathogenic Escherichia coli infection | 2.51E-02 | 3 | Q14247, O00501, P25116 | CTTN, CLDN5, F2R | More | | Sacubitril | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Sacubitril | hsa05132 | Salmonella infection | 2.03E-04 | 19 | P51617, P25963, P01375, P08238, Q9UJU2, P01106, P63261, P42338, Q13489, P10415, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754 | IRAK1, NFKBIA, TNF, HSP90AB1, LEF1, MYC, ACTG1, PIK3CB, BIRC3, BCL2, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Sacubitril | hsa05133 | Pertussis | 6.74E-06 | 4 | P05107, P0DP23, P10145, P0C0L4 | ITGB2, CALM1, IL8, C4A | More | | Sacubitril | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Sacubitril | hsa05140 | Leishmaniasis | 2.62E-08 | 13 | P13612, O75015, P14598, P42224, P13765, O60603, P25963, P01375, P29350, P49006, Q16539, P51617, Q15080 | ITGA4, FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, IRAK1, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | P13612 | ITGA4 | Integrin alpha-4 | -0.7 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | P22894 | MMP8 | Neutrophil collagenase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.734 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.708 | P22894 | MMP8 | Neutrophil collagenase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.74 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.798 | P08246 | ELA2 | Neutrophil elastase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.762 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.787 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.75 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P22894 | MMP8 | Neutrophil collagenase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.797 | P08246 | ELA2 | Neutrophil elastase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.729 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.756 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O60603 | TLR2 | Toll-like receptor 2 | -0.797 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P22894 | MMP8 | Neutrophil collagenase | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.768 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P22894 | MMP8 | Neutrophil collagenase | P01375 | TNF | Tumor necrosis factor | 0.728 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 0.808 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P49006 | MARCKSL1 | MARCKS-related protein | 0.706 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.708 | P22894 | MMP8 | Neutrophil collagenase | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.744 | P08246 | ELA2 | Neutrophil elastase | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.734 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.89 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | P22894 | MMP8 | Neutrophil collagenase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.963 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.758 | P08246 | ELA2 | Neutrophil elastase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.945 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.719 |
| Sacubitril | hsa05143 | African trypanosomiasis | 6.53E-06 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Sacubitril | hsa05144 | Malaria | 1.79E-06 | 8 | P69905, P68871, O60603, P01375, P05107, P35443, P10145, P26718 | HBA2, HBB, TLR2, TNF, ITGB2, THBS4, IL8, KLRK1 | More | | Sacubitril | hsa05145 | Toxoplasmosis | 8.39E-05 | 11 | P51617, P25963, Q16539, P01375, P10415, Q13489, P23458, P13765, Q8WYR1, P0DMV8, O60603 | IRAK1, NFKBIA, MAPK14, TNF, BCL2, BIRC3, JAK1, HLA-DOB, PIK3R5, HSPA1A, TLR2 | More | | Sacubitril | hsa05146 | Amoebiasis | 3.73E-08 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Sacubitril | hsa05150 | Staphylococcus aureus infection | 6.19E-06 | 12 | P0C0L4, P21730, P21462, O75015, P13765, Q16581, Q14532, P05107, P59665, P59666, P12838, P49913 | C4A, C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, KRT32, ITGB2, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Sacubitril | hsa05152 | Tuberculosis | 5.68E-07 | 11 | Q13488, O75015, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, Q16539, P51617 | TCIRG1, FCGR3B, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, MAPK14, IRAK1 | More | | Sacubitril | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Sacubitril | hsa05161 | Hepatitis B | 2.33E-02 | 8 | P17252, P14780, P25963, P01375, P10415, P51617, O60603, Q14765 | PRKCA, MMP9, NFKBIA, TNF, BCL2, IRAK1, TLR2, STAT4 | More | | Sacubitril | hsa05162 | Measles | 1.13E-03 | 9 | P01568, P25963, P23458, P42224, P14784, P07766, P42338, P0DMV8, P11142 | IFNA21, NFKBIA, JAK1, STAT1, IL2RB, CD3E, PIK3CB, HSPA1A, HSPA8 | More | | Sacubitril | hsa05163 | Human cytomegalovirus infection | 4.19E-04 | 10 | P42338, P25963, P62873, P63218, P50151, P0DP23, Q14344, P01106, P30101, P01568 | PIK3CB, NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, MYC, PDIA3, IFNA21 | More | | Sacubitril | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.49E-05 | 11 | P01568, P42224, P25963, P42338, P62873, P63218, P50151, P19174, P07948, P01106, P0DP23 | IFNA21, STAT1, NFKBIA, PIK3CB, GNB1, GNG5, GNG10, PLCG1, LYN, MYC, CALM1 | More | | Sacubitril | hsa05168 | Herpes simplex virus 1 infection | 6.47E-04 | 15 | P25963, P01568, Q05823, P42224, Q07955, Q01130, Q13243, Q13489, P30101, P42338, Q13398, Q9HCX3, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PDIA3, PIK3CB, ZNF211, ZNF304, ZNF140, ZNF189, ZNF212 | More | | Sacubitril | hsa05169 | Epstein-Barr virus infection | 3.41E-04 | 22 | P13765, P01106, Q13547, O00463, P25963, P16070, P10415, Q16539, P42338, P07948, P30101, Q13761, P24522, O75293, P42224, Q8WV28, P01568, P01375, O60603, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, NFKBIA, CD44, BCL2, MAPK14, PIK3CB, LYN, PDIA3, RUNX3, GADD45A, GADD45B, STAT1, BLNK, IFNA21, TNF, TLR2, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.845 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | P06737 | PYGL | Glycogen phosphorylase, liver form | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.924 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P06737 | PYGL | Glycogen phosphorylase, liver form | P16070 | CD44 | CD44 antigen | 0.803 | P06737 | PYGL | Glycogen phosphorylase, liver form | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.852 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.896 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.804 | P06737 | PYGL | Glycogen phosphorylase, liver form | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.822 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.847 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q8WV28 | BLNK | B-cell linker protein | -0.706 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P06737 | PYGL | Glycogen phosphorylase, liver form | O60603 | TLR2 | Toll-like receptor 2 | 0.836 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.839 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 |
| Sacubitril | hsa05170 | Human immunodeficiency virus 1 infection | 1.22E-05 | 22 | P42338, P62873, P63218, P50151, P0DP23, P01375, P17252, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, O95067, P19174, P07766, P10415, Q13619, Q93034, Q9Y6Q5 | PIK3CB, GNB1, GNG5, GNG10, CALM1, TNF, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, CD3E, BCL2, CUL4A, CUL5, AP1M2 | More | | Sacubitril | hsa05200 | Pathways in cancer | 1.82E-03 | 17 | P42338, P08238, P42224, P25963, P19174, P01106, P43246, Q13547, P49767, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, MSH2, HDAC1, VEGFC, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Sacubitril | hsa05202 | Transcriptional misregulation in cancer | 7.31E-17 | 23 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, Q15652, O15550, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P68431, P12980, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, JMJD1C, UTX, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q12778 | FOXO1 | Forkhead box protein O1 | 0.714 | P22894 | MMP8 | Neutrophil collagenase | Q12778 | FOXO1 | Forkhead box protein O1 | -0.72 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q12778 | FOXO1 | Forkhead box protein O1 | -0.769 | P08246 | ELA2 | Neutrophil elastase | Q12778 | FOXO1 | Forkhead box protein O1 | -0.75 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.795 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15532 | SS18 | Protein SSXT | -0.772 | P24158 | PRTN3 | Myeloblastin | Q15532 | SS18 | Protein SSXT | -0.732 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15532 | SS18 | Protein SSXT | 0.893 | P22894 | MMP8 | Neutrophil collagenase | Q15532 | SS18 | Protein SSXT | -0.867 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q15532 | SS18 | Protein SSXT | -0.803 | P08246 | ELA2 | Neutrophil elastase | Q15532 | SS18 | Protein SSXT | -0.806 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q15532 | SS18 | Protein SSXT | -0.829 | P08246 | ELA2 | Neutrophil elastase | Q13315 | ATM | Serine-protein kinase ATM | -0.742 | P08311 | CTSG | Cathepsin G | Q13315 | ATM | Serine-protein kinase ATM | -0.709 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P41732 | TSPAN7 | Tetraspanin-7 | -0.834 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P41732 | TSPAN7 | Tetraspanin-7 | 0.775 | P06737 | PYGL | Glycogen phosphorylase, liver form | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.917 | P24158 | PRTN3 | Myeloblastin | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.837 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.72 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | P22894 | MMP8 | Neutrophil collagenase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.882 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.861 | P08246 | ELA2 | Neutrophil elastase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.859 | P08311 | CTSG | Cathepsin G | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.79 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.746 | P06737 | PYGL | Glycogen phosphorylase, liver form | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.881 | P24158 | PRTN3 | Myeloblastin | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.735 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.734 | P08311 | CTSG | Cathepsin G | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.726 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14923 | JUP | Junction plakoglobin | 0.914 | P22894 | MMP8 | Neutrophil collagenase | P14923 | JUP | Junction plakoglobin | -0.809 | P08246 | ELA2 | Neutrophil elastase | P14923 | JUP | Junction plakoglobin | -0.811 | P24158 | PRTN3 | Myeloblastin | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.741 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | P08311 | CTSG | Cathepsin G | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.909 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.967 | P24158 | PRTN3 | Myeloblastin | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.802 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | P22894 | MMP8 | Neutrophil collagenase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.843 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.837 | P08246 | ELA2 | Neutrophil elastase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.766 | P08311 | CTSG | Cathepsin G | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.79 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.751 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.71 | P22894 | MMP8 | Neutrophil collagenase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.765 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.797 | P08246 | ELA2 | Neutrophil elastase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.716 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.832 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.783 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | P22894 | MMP8 | Neutrophil collagenase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.806 | P08246 | ELA2 | Neutrophil elastase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.725 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15652 | JMJD1C | Probable JmjC domain-containing histone demethylation protein 2C | 0.754 | P06737 | PYGL | Glycogen phosphorylase, liver form | O15550 | UTX | Lysine-specific demethylase 6A | 0.724 | P24158 | PRTN3 | Myeloblastin | O15550 | UTX | Lysine-specific demethylase 6A | 0.776 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O15550 | UTX | Lysine-specific demethylase 6A | -0.808 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O15550 | UTX | Lysine-specific demethylase 6A | 0.789 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | O15550 | UTX | Lysine-specific demethylase 6A | 0.73 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O15550 | UTX | Lysine-specific demethylase 6A | -0.778 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P04637 | TP53 | Cellular tumor antigen p53 | 0.753 | P06737 | PYGL | Glycogen phosphorylase, liver form | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.73 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P22894 | MMP8 | Neutrophil collagenase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.821 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.779 | P08246 | ELA2 | Neutrophil elastase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.824 | P06737 | PYGL | Glycogen phosphorylase, liver form | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.73 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | P22894 | MMP8 | Neutrophil collagenase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.821 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.779 | P08246 | ELA2 | Neutrophil elastase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.824 | P06737 | PYGL | Glycogen phosphorylase, liver form | P05164 | MPO | Myeloperoxidase | 0.858 | P24158 | PRTN3 | Myeloblastin | P05164 | MPO | Myeloperoxidase | 0.979 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P05164 | MPO | Myeloperoxidase | -0.754 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | P22894 | MMP8 | Neutrophil collagenase | P05164 | MPO | Myeloperoxidase | 0.905 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P05164 | MPO | Myeloperoxidase | 0.805 | P08246 | ELA2 | Neutrophil elastase | P05164 | MPO | Myeloperoxidase | 0.903 | P08311 | CTSG | Cathepsin G | P05164 | MPO | Myeloperoxidase | 0.956 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P05164 | MPO | Myeloperoxidase | 0.711 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P06737 | PYGL | Glycogen phosphorylase, liver form | P12838 | DEFA4 | Neutrophil defensin 4 | 0.7 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | P08246 | ELA2 | Neutrophil elastase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.709 | P08311 | CTSG | Cathepsin G | P12838 | DEFA4 | Neutrophil defensin 4 | 0.817 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08246 | ELA2 | Neutrophil elastase | 0.817 | P24158 | PRTN3 | Myeloblastin | P08246 | ELA2 | Neutrophil elastase | 0.894 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P08246 | ELA2 | Neutrophil elastase | -0.833 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | P22894 | MMP8 | Neutrophil collagenase | P08246 | ELA2 | Neutrophil elastase | 0.985 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.846 | P08246 | ELA2 | Neutrophil elastase | P08246 | ELA2 | Neutrophil elastase | 1 | P08311 | CTSG | Cathepsin G | P08246 | ELA2 | Neutrophil elastase | 0.792 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.742 | P24158 | PRTN3 | Myeloblastin | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.777 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.741 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | P22894 | MMP8 | Neutrophil collagenase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.778 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.808 | P08246 | ELA2 | Neutrophil elastase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.75 | P08311 | CTSG | Cathepsin G | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.853 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.879 | P06737 | PYGL | Glycogen phosphorylase, liver form | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.847 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | -0.79 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | P06737 | PYGL | Glycogen phosphorylase, liver form | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.822 | P24158 | PRTN3 | Myeloblastin | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.772 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.768 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | P22894 | MMP8 | Neutrophil collagenase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.766 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.764 | P08246 | ELA2 | Neutrophil elastase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.7 | P08311 | CTSG | Cathepsin G | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.799 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 |
| Sacubitril | hsa05203 | Viral carcinogenesis | 8.69E-05 | 15 | Q99941, P18848, P42338, P06746, P07948, P27348, P29083, Q13547, Q15283, P61586, P12814, P25963, P61978, P62807, Q93079 | CREBL1, ATF4, PIK3CB, POLB, LYN, YWHAQ, GTF2E1, HDAC1, RASA2, RHOA, ACTN1, NFKBIA, HNRPK, HIST1H2BC, H2BC9 | More | | Sacubitril | hsa05205 | Proteoglycans in cancer | 2.66E-02 | 8 | Q14643, P63261, P04637, P14780, P17252, O60603, Q13635, P08962 | ITPR1, ACTG1, TP53, MMP9, PRKCA, TLR2, PTCH1, CD63 | More | | Sacubitril | hsa05206 | MicroRNAs in cancer | 1.34E-03 | 13 | P30304, P09493, P21860, P01106, P42338, P61978, P46531, Q13547, P63279, P22105, P61586, P20827, P19174 | CDC25A, TPM1, ERBB3, MYC, PIK3CB, HNRPK, NOTCH1, HDAC1, UBE2I, TNXB, RHOA, EFNA1, PLCG1 | More | | Sacubitril | hsa05214 | Glioma | 1.34E-02 | 4 | P0DP23, P42338, P19174, O75293 | CALM1, PIK3CB, PLCG1, GADD45B | More | | Sacubitril | hsa05216 | Thyroid cancer | 3.59E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Sacubitril | hsa05217 | Basal cell carcinoma | 4.56E-04 | 5 | Q13635, P49841, Q9UJU2, P04637, P24522 | PTCH1, GSK3B, LEF1, TP53, GADD45A | More | | Sacubitril | hsa05218 | Melanoma | 2.31E-02 | 3 | Q9NRA1, P42338, O75293 | PDGFC, PIK3CB, GADD45B | More | | Sacubitril | hsa05220 | Chronic myeloid leukemia | 2.17E-02 | 5 | Q13547, P01106, P25963, P42338, O75293 | HDAC1, MYC, NFKBIA, PIK3CB, GADD45B | More | | Sacubitril | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Sacubitril | hsa05231 | Choline metabolism in cancer | 2.92E-03 | 5 | P42338, Q9NRA1, Q9Y259, P19174, P23743 | PIK3CB, PDGFC, CHKB, PLCG1, DGKA | More | | Sacubitril | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.14E-05 | 12 | P25963, P42338, O95267, P19174, P07766, P20963, P09693, P06239, P42224, O60603, P10747, Q04759 | NFKBIA, PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, STAT1, TLR2, CD28, PRKCQ | More | | Sacubitril | hsa05310 | Asthma | 6.61E-07 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Sacubitril | hsa05321 | Inflammatory bowel disease | 1.77E-16 | 8 | O60603, P01375, P13765, Q14765, Q9UL17, P42226, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, STAT6, GATA3, IL21R | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | O60603 | TLR2 | Toll-like receptor 2 | 0.836 | P24158 | PRTN3 | Myeloblastin | O60603 | TLR2 | Toll-like receptor 2 | 0.729 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P22894 | MMP8 | Neutrophil collagenase | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.942 | P08246 | ELA2 | Neutrophil elastase | O60603 | TLR2 | Toll-like receptor 2 | 0.853 | P15144 | ANPEP | Aminopeptidase N | O60603 | TLR2 | Toll-like receptor 2 | 0.885 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P24158 | PRTN3 | Myeloblastin | P01375 | TNF | Tumor necrosis factor | 0.719 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | P22894 | MMP8 | Neutrophil collagenase | P01375 | TNF | Tumor necrosis factor | 0.728 | P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P15144 | ANPEP | Aminopeptidase N | P01375 | TNF | Tumor necrosis factor | 0.878 | P06737 | PYGL | Glycogen phosphorylase, liver form | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.845 | P24158 | PRTN3 | Myeloblastin | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.796 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | P22894 | MMP8 | Neutrophil collagenase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.797 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.792 | P08246 | ELA2 | Neutrophil elastase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.729 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.736 | P24158 | PRTN3 | Myeloblastin | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.753 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | P22894 | MMP8 | Neutrophil collagenase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.757 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.701 | P08246 | ELA2 | Neutrophil elastase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.783 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P15144 | ANPEP | Aminopeptidase N | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.86 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.738 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P15144 | ANPEP | Aminopeptidase N | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.755 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06737 | PYGL | Glycogen phosphorylase, liver form | P42226 | STAT6 | Signal transducer and activator of transcription 6 | 0.852 | P06737 | PYGL | Glycogen phosphorylase, liver form | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.753 | P24158 | PRTN3 | Myeloblastin | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.81 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | P22894 | MMP8 | Neutrophil collagenase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.751 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.768 | P08246 | ELA2 | Neutrophil elastase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.724 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 |
| Sacubitril | hsa05322 | Systemic lupus erythematosus | 4.18E-04 | 10 | O75015, P08246, P08311, P01375, P10747, P13765, Q6FI13, Q16778, P12814, P05455 | FCGR3B, ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST2H2BE, ACTN1, SSB | More | | Sacubitril | hsa05323 | Rheumatoid arthritis | 1.08E-04 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Sacubitril | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Sacubitril | hsa05332 | Graft-versus-host disease | 1.28E-12 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Sacubitril | hsa05340 | Primary immunodeficiency | 3.73E-02 | 2 | P11912, P16871 | CD79A, IL7R | More | | Sacubitril | hsa05410 | Hypertrophic cardiomyopathy | 2.60E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Sacubitril | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Sacubitril | hsa05415 | Diabetic cardiomyopathy | 6.60E-04 | 12 | P17252, P05141, P12236, P14598, Q15080, O15239, Q16718, O14521, P05496, Q13557, P04406, P26678 | PRKCA, SLC25A5, SLC25A6, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, ATP5G1, CAMK2D, GAPDH, PLN | More | | Sacubitril | hsa05416 | Viral myocarditis | 2.30E-02 | 2 | P10747, P63261 | CD28, ACTG1 | More | | Sacubitril | hsa05418 | Fluid shear stress and atherosclerosis | 4.26E-02 | 6 | P14598, P14780, P63261, P04637, P10415, Q92974 | NCF1, MMP9, ACTG1, TP53, BCL2, ARHGEF2 | More | | |